Picture of Zimmer Biomet Holdings logo

ZBH — Zimmer Biomet Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Zimmer Biomet Holdings Inc reports results for the quarter ended June 30 - Earnings Summary

Zimmer Biomet Holdings Inc ZBH.N reported quarterly adjusted earnings of $2.07​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.01.  The mean expectation of twenty six analysts for the quarter was for earnings of $1.98 per share. Wall Street expected results to range from $1.79  to $2.07 per share.

Revenue rose 7% to $2.08 billion from a year ago; analysts expected $2.05 billion.

Zimmer Biomet Holdings Inc's reported EPS for the quarter was 77 cents​.

The company reported quarterly net income of $152.8 million.

Zimmer Biomet Holdings Inc shares had fallen by 0.1% this quarter and lost 13.7% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 0.3% in the last three months.​

In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 11 "strong buy" or "buy," 17 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."

Wall Street's median 12-month price target for Zimmer Biomet Holdings Inc is $105.00, about 6.3% above its last closing price of $98.43

This summary was machine generated from LSEG data August 8 at 02:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
Jun. 30 20251.982.07Beat
Mar. 31 20251.771.81Beat
Dec. 31 20242.302.31Beat
Sep. 30 20241.741.74Met

Recent news on Zimmer Biomet Holdings

See all news